# US 2012/0252053 A1 · Reagents and methods and systems using them

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252053 A1
- Document ID: US20120252053A1
- Status: Published application
- Kind: A1
- Application number: 13/493,139
- Filed: 2012-06-11
- Published: 2012-10-04
- Earliest claimed: 2010-09-30
- Assignees: Magellan Biosciences Point-of-Care, Inc.
- Inventors: W. James Scott
- Web page: https://patentgrep.com/patent/US20120252053A1

## CPC

- G01N 33/84: involving inorganic compounds or pH
- Y10S 435/81: Packaged device or kit
- Y10T 436/107497: Preparation composition [e.g., lysing or precipitation, etc.]
- Y10T 436/108331: Preservative, buffer, anticoagulant or diluent
- Y10T 436/23: Carbon containing
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Certain embodiments described herein are directed to a reagent that includes an effective amount of an adsorber to remove interfering species present during heavy metal level measurement in a fluid sample. In some examples, the reagent can include an effective amount of an adsorber to remove a suitable amount of glutathione from the fluid sample such that the glutathione does not interfere with measurements of lead levels in the fluid sample.

## Claims

### Claim at position 1

1-40. (canceled)

### Claim 41

A method of measuring a level of a heavy metal in a mammalian fluid sample, the method comprising:
adding the mammalian fluid sample to a container comprising an effective amount of a lysing agent to lyse cells in the mammalian fluid sample and an effective amount of an adsorber to adsorb sulfhydryl species present in the lysed fluid sample; and
detecting the level of the heavy metal present in the lysed fluid sample.

### Claim 42 (depends on 41)

The method of claim 41, further comprising configuring the lysing agent to lyse the cells and not remove substantial amounts of heavy metal from the mammalian fluid sample.

### Claim 43 (depends on 41)

The method of claim 41, further comprising configuring the lysing agent to be an acid.

### Claim 44 (depends on 41)

The method of claim 41, further comprising detecting lead in the lysed fluid sample using a gold colloid sensor.

### Claim 45 (depends on 41)

The method of claim 41, further comprising configuring the adsorber to be effective to adsorb glutathione in the mammalian fluid sample.

### Claim 46 (depends on 41)

The method of claim 41, further comprising configuring the adsorber as a powder that comprises an average particle size of less than or equal to 100 microns.

### Claim 47 (depends on 41)

The method of claim 41, further comprising configuring the adsorber as a powder that comprises a surface area of at least 1000 m2/g.

### Claim 48 (depends on 41)

The method of claim 41, further comprising configuring the adsorber as a powdered activated carbon.

### Claim 49 (depends on 48)

The method of claim 48, further comprising configuring the adsorber with a non-activated carbon.

### Claim 50 (depends on 41)

The method of claim 41, further comprising configuring the mammalian fluid sample as fresh blood.

### Claim 51

A method of facilitating measurement of a heavy metal in a mammalian fluid sample, the method comprising providing an effective amount of an adsorber to be added to a treatment reagent selected to lyse cells in the mammalian fluid sample.

### Claim 52 (depends on 51)

The method of claim 51, further comprising providing a sensor configured to bind to the heavy metal in the lysed, mammalian fluid sample.

### Claim 53 (depends on 52)

The method of claim 52, further comprising providing a device configured to read the sensor with bound heavy metal.

### Claim 54 (depends on 51)

The method of claim 51, further comprising providing a container comprising heparin and configured to receive the mammalian fluid sample.

### Claim 55 (depends on 51)

The method of claim 51, further comprising configuring the treatment reagent as an effective amount of an acid to lyse the cells.

### Claim 56

A method of facilitating measurement of lead in a mammalian blood sample, the method comprising providing an effective amount of an adsorber to be added to a treatment reagent selected to lyse cells in the mammalian blood sample.

### Claim 57 (depends on 56)

The method of claim 56, further comprising providing a sensor configured to bind to the lead in the lysed, mammalian blood sample.

### Claim 58 (depends on 57)

The method of claim 57, further comprising providing a device configured to read the sensor with bound lead.

### Claim 59 (depends on 56)

The method of claim 56, further comprising providing a container comprising heparin and configured to receive the mammalian blood sample.

### Claim 60 (depends on 56)

The method of claim 56, further comprising configuring the treatment reagent as an effective amount of hydrochloric acid to lyse the cells.
